We are one of 26 partners in the European public-private partnership Real world Outcomes across the Alzheimer’s Disease spectrum for better care: Multi‐modal data Access Platform (ROADMAP).
The project provides the foundation for an integrated data environment and framework for real-world evidence.
We are one of 29 partners in the European public-private partnership Accelerated development of vaccine benefit-risk collaboration in Europe (ADVANCE).
The aim of ADVANCE is to review, develop and test methods, data sources and procedures which should feed into a blueprint of an efficient and sustainable pan-European framework that can deliver robust quantitative data for the assessment of the benefits and risks of vaccines on the market.
We are one of 56 partners in the European public-private partnership European Medical Information Framework (EMIF).
The overall aim of EMIF is to develop common technical and governance solutions and improve access and use of health data in Europe. A common information framework will facilitate access to diverse medical and research data sources. EMIF includes two specific research topics to help guide the development of the information framework: the onset of Alzheimer’s disease and metabolic complications of obesity.
DCE is a proud member of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP), launched by the EMA. The network aims to strengthen the monitoring of post-marketed medical products in Europe.
DCE represents academia in the ENCePP Steering Group in the 2017-2019 term.
Since 2006, DCE has been a member of the International Clinical Epidemiology Network (INCLEN). INCLEN is a non-profit organisation, which seeks to increase the knowledge of clinical epidemiology among clinicians and other researchers to help improve the health of people in the developing world.
DCE is a certified Clinical Epidemiology Research Training Centre within INCLEN and frequently hosts researchers from other partners of the network.